Accuray Inc (STU:XEJ)
€ 0.25 +0.044 (+21.78%) Market Cap: 29.82 Mil Enterprise Value: 155.69 Mil PE Ratio: 0 PB Ratio: 0.80 GF Score: 43/100

Q3 2024 Accuray Inc Earnings Call Transcript

May 01, 2024 / 08:30PM GMT
Release Date Price: €1.99

Key Points

Positve
  • Accuray Inc (ARAY) reported a 21% global order growth in Q3, and an 8% growth on a trailing 12-month basis, indicating strong customer adoption of product innovations.
  • The company's installed base grew by 4% year-over-year, with service contract revenue growing 2% year-over-year and 4% on a trailing 12-month basis, suggesting a steady increase in long-term revenue streams.
  • Accuray Inc (ARAY) received regulatory approval to market the Tono C equipment in China, a significant step towards expanding its market presence in the region.
  • The EIMEA region showed robust performance with a 5% revenue growth and 29% order growth on a trailing 12-month basis, indicating strong market traction and potential for continued expansion.
  • Accuray Inc (ARAY) is actively investing in global training centers and partnerships, such as with IUCT Oncopole and Airbus, to enhance service offerings and drive future revenue growth.
Negative
  • Accuray Inc (ARAY) experienced a disappointing quarter with significant near-term challenges, including delayed shipments and a slowdown in the US market, impacting financial results.
  • The company faced a substantial slowdown in the US due to longer capital equipment budget cycles, contributing to a 38% year-over-year revenue decline in the Americas region for Q3.
  • Three expected system shipments were delayed to Q4, affecting the company's revenue and adjusted EBITDA for the quarter.
  • Accuray Inc (ARAY) is still awaiting regulatory approval for the precision treatment planning system in China, which is necessary to fully capitalize on the Tono C equipment's market potential.
  • The company's overall gross margin for Q3 decreased to 28.7% from 32.8% in the prior year, influenced by increased China margin deferral and unfavorable foreign exchange impacts.
Operator

Good afternoon, and welcome to the Accuray conference call to review financial results for the third quarter of fiscal year 2024, which ended March 31, 2024. (Operator Instructions) Please note this event is being recorded.

I would now like to turn the conference over to Mr. Jesse Chew. Please go ahead.

Jesse Chew
Accuray Inc - Senior Vice President, Chief Legal Officer and Corporate Secretary

Thank you, operator, and good afternoon, everyone. Welcome to Accuray's conference call to review financial results for the third quarter of fiscal year 2024, which ended March 31, 2024. During our call this afternoon, management will review recent corporate developments. Joining us on today's call are Suzanne Winter, ACR's President and Chief Executive Officer; and Ali Parvez, Accuray's Chief Financial Officer. Before we begin, I would like to remind you that our call today includes forward-looking statements. Actual results may differ materially from those contempleted or implied by these forward-looking statements.

Factors that could cause these

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot